Bayer

Bayer goes into bat for Yas

BAYER Pharma AG and Bayer Australia Limited have gone into bat to protect the company’s oral contraceptives Yas and Yasmin, launching Federal Court proceedings yesterday against Lupin Australia and Generic Health.

The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 17 Feb 12

CLICK HERE to download Pharmacy Daily from 17 Feb 12

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

19 Apr   Dispensary Corner 19 Apr 12 - SHE may need glasses. An American woman ...

19 Apr   Antibiotic expectations - ONE in five Australians have an expectation ...

19 Apr   COPD mortality rate drops - THE number of Australians dying due to ...

19 Apr   Young leaves NZ Guild - THE Chief Executive of the Pharmacy Guild ...

19 Apr   CHC on regulation - A RECENT Murdoch University study into Traditional ...

19 Apr   Bosisto’s turns 160 - TO celebrate its 160th birthday, Bosisto’s is ...

19 Apr   API experiences growth - API has reported half year net profit ...

19 Apr   Say thank you mum - THIS week P&G launched a global Say ...

18 Apr   Estee has invisible makeup - Estee Lauder’s new Invisible Fluid Makeup has ...

18 Apr   Glow with Tom Ford this Autumn - Autumn is heating up with the launch ...

18 Apr   Get your iodine in a spray - BioCeuticals’ new practitioner-only once-daily Iodine Forte oral ...

18 Apr   CK shocks both she and he - ...

18 Apr   Dispensary Corner 18 Apr 12 - SHOT by a dumbell. A US man ...

18 Apr   J&J sees 2012 dip - JOHNSON & Johnson sales decreased 0.2% year-on-year ...

18 Apr   Needle-free is a winner - VAXXAS’ new needle-free vaccine delivery system, Nanopatch, ...

18 Apr   Abbott’s biomarkers - ABBOTT has secured an exclusive license for ...

18 Apr   Repeat offenders slammed - THE Pharmacy Board of Australia has slammed ...

18 Apr   Addiction risks - OPIOIDS have the highest risk of causing ...

18 Apr   Australians and the flu - MANY Australians avoid flu vaccinations and instead ...

18 Apr   Unhealthy athletics - THE tide of unhealthy advertising in the ...

Show Pharmacy Daily items by month: